Literature DB >> 26439760

Ultramicro-trauma in the endometrial-myometrial junctional zone and pale cell migration in adenomyosis.

Mohamed G Ibrahim1, Vito Chiantera1, Sergio Frangini1, Shadi Younes1, Christhardt Köhler2, Eliane T Taube3, Johanna Plendl4, Sylvia Mechsner5.   

Abstract

OBJECTIVE: To determine if ultrastructural tissue trauma occurs in the junctional zone in uteri in adenomyosis.
DESIGN: A case-control experimental study.
SETTING: Endometriosis research center. PATIENT(S): Twelve uteri with adenomyosis, and 9 uteri without adenomyosis, were gained during laparoscopy-assisted vaginal hysterectomy. INTERVENTION(S): Transmission electron microscopic study of the junctional zone, as well as immunohistochemical staining for epithelial cadherin, and van Gieson staining and immunofluorescence for CD45 and CD68. MAIN OUTCOME MEASURE(S): Analysis of the electron microscopy photos and the immunoreactive scores of the staining. RESULT(S): The inner myometrial muscle fibers were diversely arranged in adenomyosis; they were parallel to the basal endometrial glands in nonadenomyosis. Nuclear membrane infolding of the basal glandular epithelium and the disruption of the interface between basal endometrium and inner myometrium in adenomyosis (but not in nonadenomyosis) were evident. Intraepithelial pale cells were seen in the basal endometrial glands in both groups, but they lacked CD45 and CD68 expression. They were seen actively migrating into the stroma in adenomyosis only. CONCLUSION(S): The myofiber disarray in the inner myometrium, and the nuclear membrane irregularities in adenomyosis, are evidence for ultramicro-trauma in adenomyosis. The migrating nonleukocytic pale cells may be involved in pathogenesis of adenomyosis.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenomyosis pathogenesis; endometrial-myometrial junctional zone; pale cells; ultrastructure

Mesh:

Substances:

Year:  2015        PMID: 26439760     DOI: 10.1016/j.fertnstert.2015.09.002

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Adenomyosis: Mechanisms and Pathogenesis.

Authors:  Junyu Zhai; Silvia Vannuccini; Felice Petraglia; Linda C Giudice
Journal:  Semin Reprod Med       Date:  2020-10-08       Impact factor: 1.303

2.  Archimetrosis: the evolution of a disease and its extant presentation : Pathogenesis and pathophysiology of archimetrosis (uterine adenomyosis and endometriosis).

Authors:  Gerhard Leyendecker; Ludwig Wildt; Matthias W Laschke; Gerhard Mall
Journal:  Arch Gynecol Obstet       Date:  2022-05-21       Impact factor: 2.344

3.  Mode Switch of Ca2 + Oscillation-Mediated Uterine Peristalsis and Associated Embryo Implantation Impairments in Mouse Adenomyosis.

Authors:  Mingzi Qu; Ping Lu; Karl Bellve; Lawrence M Lifshitz; Ronghua ZhuGe
Journal:  Front Physiol       Date:  2021-11-04       Impact factor: 4.755

Review 4.  Pathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility.

Authors:  Khaleque N Khan; Akira Fujishita; Taisuke Mori
Journal:  J Clin Med       Date:  2022-07-13       Impact factor: 4.964

5.  Identification of endometriosis-associated genes and pathways based on bioinformatic analysis.

Authors:  Ting Wang; Ruoan Jiang; Yingsha Yao; Linhua Qian; Yu Zhao; Xiufeng Huang
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

Review 6.  Uterine Stem Cells and Benign Gynecological Disorders: Role in Pathobiology and Therapeutic Implications.

Authors:  Malak El Sabeh; Sadia Afrin; Bhuchitra Singh; Mariko Miyashita-Ishiwata; Mostafa Borahay
Journal:  Stem Cell Rev Rep       Date:  2020-11-05       Impact factor: 6.692

Review 7.  Stem Cells and the Endometrium: From the Discovery of Adult Stem Cells to Pre-Clinical Models.

Authors:  Lucía de Miguel-Gómez; Sara López-Martínez; Emilio Francés-Herrero; Adolfo Rodríguez-Eguren; Antonio Pellicer; Irene Cervelló
Journal:  Cells       Date:  2021-03-08       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.